Live tape
Top 8, mentions 7d7,377SPCX1,446 mentions▲ +0.09GOOGL1,354 mentions▲ +0.05NVDA1,199 mentions▲ +0.09MSFT846 mentions▲ +0.04QQQ697 mentions▲ +0.08META640 mentions▲ +0.04SPY602 mentions▲ +0.06AMZN593 mentions▲ +0.07

Equity · Healthcare

BLFS

NASDAQ

BioLife Solutions, Inc.

$38.58 +3.50% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 5, 2026
Price · Chart
60 sessions
$40 $25 13 Jul 5 Oct

The line runs $28.10 on 13 July through $38.58 on 5 October, on a scale from $25 to $40. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 60 sessions, 13 Jul – 5 Oct 2026
Market cap $1.9B
P/E (TTM) 33.3
52-week range $18.15 – $39
Avg volume 59.4K

as of Oct 5, 2026

BLFS insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 18 Sep 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 9

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
18 Sep 2026 Wichterman Troy Chief Financial Officer Tax withheld 937 $34K
18 Sep 2026 DE GREEF RODERICK President and CEO Tax withheld 2,775 $102K
18 Sep 2026 Werner Sean Chief Technology Officer Tax withheld 421 $15K
18 Sep 2026 Mathew Aby J. EVP & Chief Scientific Officer Tax withheld 564 $21K
18 Sep 2026 Berard Todd Chief Marketing Officer Tax withheld 470 $17K
08 Sep 2026 Wichterman Troy Chief Financial Officer Tax withheld 1,026 $36K
08 Sep 2026 Mathew Aby J. EVP & Chief Scientific Officer Tax withheld 627 $22K
08 Sep 2026 Berard Todd Chief Marketing Officer Tax withheld 356 $13K
17 Jul 2026 Werner Sean Chief Technology Officer Tax withheld 275 $8K

BLFS reported financials

SEC EDGAR XBRL SEC EDGAR

BLFS reported revenue of $96.2M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$4.6M.

Figure Reported Period
Revenue $96.2M 31 Dec 2025 fiscal year
Net income −$4.6M 31 Dec 2025 fiscal year
Diluted EPS −$0.10 31 Dec 2025 fiscal year
Total assets $447.5M 30 Jun 2026 at period end
Total equity $420.0M 30 Jun 2026 at period end

BLFS earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.91 —
31 Mar 2026 Q1 2026 $0.02 —
31 Dec 2025 FY 2025 −$0.10 —
30 Sep 2025 Q3 2025 $0.01 —
30 Jun 2025 Q2 2025 −$0.33 —
31 Mar 2025 Q1 2025 $0.00 —
31 Dec 2024 FY 2024 −$0.44 —
30 Sep 2024 Q3 2024 −$0.04 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

BLFS institutional holders

SEC Form 13F SEC EDGAR

7 of the 45 institutional funds we track reported a BLFS position for the quarter ended 30 Jun 2026 — a combined $28.7M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Millennium Management New position 625,658 $17.7M
Citadel Advisors Trimmed −35.3% shares 157,944 $4.5M
Man Group Added +100.3% shares 145,503 $4.1M
Point72 Asset Management New position 35,019 $989K
Marshall Wace New position 23,692 $669K
AQR Capital Management New position 15,739 $444K
D. E. Shaw & Co. Trimmed −87.9% shares 12,349 $349K
Renaissance Technologies Exited

BLFS fails-to-deliver

SEC CNS data SEC

On 02 Sep 2026, 12 shares of BLFS failed to deliver (about $426).

Settlement date Shares failed Notional % of shares out
02 Sep 2026 12 $426 <0.001%

Congressional trades in BLFS

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in BLFS is a sale by Sara Jacobs (house, CA), dated 12 Dec 2022.

Date Member Type Amount
12 Dec 2022 filed 20 Jan 2023 Sara Jacobs house · Democrat–CA Sale $1K–$15K

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings